![](/sites/default/files/styles/medium/public/oembed_thumbnails/62EhYFnqhDHz-SqQmLOD37xGXLFNexaatd97h90bi8M.jpg?itok=7GIQTy6i)
Dr. Boustani is a geriatrician, a neuroscientist, and implementation scientist with extensive experience in developing, evaluating, implementing and disseminating healthcare innovations focusing on brain health. He is Director of Senior Care Innovation at Eskenazi Health and the Chief Innovation and Implementation Officer for Indiana University Center for Health Innovation and Implementation Science. He has built a clinical laboratory of more than 2,000 ambulatory practices serving at least 10 million lives across five Midwestern States. With this laboratory, he led the execution of many clinical research studies totaling more than $100 million. To detect cognitive impairment, reduce exposure to potentially harmful medications and procedures, and enhance the recovery of brain health after critical illness, he developed a combined human- and computer-based decision support system. He contributed to the identification of acute and chronic adverse cognitive effects of medications and developed the anticholinergic cognitive burden scale. This led to the discovery that exposure to medications with adverse cognitive effect may lead to future development of dementia including Alzheimer's disease and mild cognitive impairment. His Aging Brain Care model in primary care achieves the quadruple aim of improving brain health, improving brain care and reducing cost with enhanced patient and clinician experiences, and has become the standard of brain care across the world. Visit Barnes & Noble to learn more about Malaz Boustani's latest book Agile Implementation.